Solid tryptophan as a pseudoracemate: Physicochemical and crystallographic characterization

Chirality

Volumn 27, Issue 1, 2015, Pages 88-94

  Li, Yan ^a   Zhao, Yuming ^a   Zhang, Yan ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Phase diagram; Racemicmodification; Solid solution; Tryptophan; X ray crystallography

Indexed keywords

2 PROPANOL; TRYPTOPHAN; WATER;

ARTICLE; CHIRALITY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; ENANTIOMER; GEOMETRY; HYDROGEN BOND; MELTING POINT; PHYSICAL CHEMISTRY; POWDER DIFFRACTION; RACEMIC MIXTURE; SOLID STATE; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY; CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; MODELS, MOLECULAR; STEREOISOMERISM;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; MODELS, MOLECULAR; STEREOISOMERISM; TRYPTOPHAN;

EID: 84920131983     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.22399     Document Type: Article

References (32)

1. Subramanian G, Chiral separation techniques - A practical approach. Weinheim, Germany: Wiley-VCH; 2001.
2. Jacques J, Collet A, Wilen SH. Enantiomers, racemates and resolution. New York: Wiley; 1981.
3. Stahly GP, Byrn SR. The solid-state structure of chiral organic pharmaceuticals. In: Myerson AS, editor. Molecular modeling applications in crystallization. Cambridge, UK: Cambridge University Press; 1999.
4. Zhang GG, Paspal SY, Suryanarayanan R, Grant DJ. Racemic species of sodium ibuprofen: Characterization and polymorphic relationships. J Pharm Sci 2003;92:1356-1366.
5. Takiyama H, Suzuki H, Uchida H, Matsuoka M. Determination of solid- liquid phase equilibria by using measured DSC curves. Fluid Phase Equilibr 2002;194-197:1107-1117.
6. Sapoundjiev D, Lorenz H, Seidel-Morgenstern A. Solubility of chiral threonine species in water/ethanol mixtures. J Chem Eng Data 2006;51:1562-1566.
7. Worlitschek J, Bosco M, Huber M, Gramlich V, Mazzotti M. Solid-liquid equilibrium of Tröger's base enantiomers in ethanol: experiments and modelling. Helv Chim Acta 2004;87:279-291.
8. Zhang Y, Ray AK, Rohani S. Measurement and prediction of phase diagrams of the enantiomeric 3-chloromandelic acid system. Chem Eng Sci 2009;64:192-197.
9. Bredikhin AA, Bredikhina ZA, Zakharychev DV, Gubaidullin AT, Fayzullin RR. Chiral drug timolol maleate as a continuous solid solution: Thermochemical and single crystal X-ray evidence. Cryst Eng Comm 2012;14:648-655.
10. Balawejdera M, Mossety-Leszczakb B, Poplewskad I, Lorenzc H, Seidel- Morgenstern A, Piatkowski W, Antos D. Modeling and predictions of solid-liquid equilibria for citalopram oxalate as a representative of a solid solution forming system, Fluid Phase Equilibr 2013;346:8-19.
11. Kozma D, CRC handbook of optical resolution via diastereomeric salt formation, Boca Raton, FL: CRC Press; 2001.
12. Lorenz H, Polenske D, Seidel-Morgenstern A. Application of preferential crystallization to resolve racemic compounds in a hybrid process. Chirality 2006;18:828-840.
13. Zhang Y, Mao S, Ray AK, Rohani S. Nucleation and growth kinetics of (R)-mandelic acid from aqueous solution in the presence of the opposite enantiomer. Cryst Growth Des 2010;10:2879-2887.
14. Codan L, Eckstein CF, Mazzotti M. Growth kinetics of S-mandelic acid in aqueous solutions in the presence of R-mandelic acid. Cryst Growth Des 2013;13:652-663.
15. Lorenz H, Seidel-Morgenstern A. A contribution to the mandelic acid phase diagram. Thermochim Acta 2004;415:55-61.
16. Li ZJ, Zell MT, Munson EJ, Grant DJW. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies. J Pharm Sci 1999;88:337-346.
17. Tabora JE, Corry J, Osifchin R, Lepore JV, Davidson OA, Thien MP. Identification and characterization of an anomalous racemate. Fluid Phase Equilib 2007;258:140-147.
18. Klussmann M, White AJP, Armstrong, A, Balckmond DG. Rationalization and prediction of solutionenantiomeric excess in ternary phase systems. Angew Chem Int Ed 2006;45:7985-7989.
19. Huang J, Chen S, Guzei IA, Yu L. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding. J Am Chem Soc 2006;128:11985-11992.
20. De Diego HL, Bond AD, Dancer RJ. Formation of solid solutions between racemic and enantiomeric citalopram oxalate. Chirality 2011;23:408-416.
21. Gu C-H, Grant DJW. Effects of crystal structure and physical properties on the release of chiral drugs. In: Reddy IK, Mehvar R, editors. Chirality in drug design and development. New York: CRC Press; 2004.
22. Schneider-Helmet D, Spinweber CL. Evaluation of L-tryptophan for treatment of insomnia: A review. Psychophamcology 1986;89:1-7.
23. Thomson J, Rankin H, Ashcroft GW, Yates CM, McQueen JK, Cummings SW. The treatment of depression in general practice: A comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. Psychol Med 1982;12:741-751.
24. Dong J, Trieu TH, Shi X, Zhang Q, Xiao S, Lu X. A general strategy for the highly stereoselective synthesis of HR22C16-like mitotic kinesin Eg5 inhibitors from both L- And D-tryptophans. Tetrahedron: Asymmetry 2011;22:1865-1873.
25. Sheldrick GM. A short history of SHELX. Acta Crystallogr A 2008;64:112-122.
26. Mercury, Version 3.3, Cambridge Crystallographic Data Centre, Cambridge, UK, 2001-2013.
27. Görbitz CH, Törnroos KW, Day GM. Single-crystal investigation of L-tryptophan with Z′ = 16. Acta Crystallogr B 2012;68:549-557.
28. Mason SF. Molecular optical activity and chiral discriminations, Cambridge, UK: Cambridge University Press; 1982.
29. Descamps G, Cartigny Y, Sanselme M, Petit M-N, Petit S, Aubin E, Coquerel G. Structural and physicochemical characterization of a solid solution produced by antisolvent crystallization of a new phosphoantigen. Cryst Growth Des 2009;9:3910-3917.
30. Brandel C, Amharar Y, Rollinger JM, Griesser UJ, Cartigny Y, Petit S, Coquerel G. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers. Mol Pharm 2013;10:3850-3861.
31. Bakke Ø, Mostad A. The structure and conformation of tryptophan in the crystal of the pure racemic compound and the hydrogen oxalate. Acta Chem Scand B 1980;34:559-570.
32. Hübschle CB, Messerschmidt M, Luger P Crystal structure of DLtryptophan at 173 K. Cryst Res Technol 2004;39:274-278.